Irinotecan,Leucovorin,Gemcitabine,Nab-paclitaxel
ipsen
[]
much anticipated data from study napoli-3 showing survival benefit with nalirifox in #pancreaticcancer . interestingly mos of 11.1m is equal to mos of prodige study with folfirinox. rates of g3/4 diarrhea higher with onivyde regimen than reported with ffx. #gi23 
Medical Oncologist at @OchsnerHealth in New Orleans specializing in GI cancers. Gators, Jaguars Fan. All opinions are my own.